InflaRx N.V. Banner Image

InflaRx N.V.

  • Ticker IFRX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
InflaRx N.V. Logo Image
  • 11-50 Employees
  • Based in Jena, Germany
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. Complement C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. InflaRx was founded in 2007, and the groupMore has offices and subsidiaries in Jena and Munich, Germany, as well as Ann Arbor, MI, USA.
4.7 / 5.0 (119)

InflaRx N.V. reports have an aggregate usefulness score of 4.7 based on 119 reviews.

InflaRx N.V.

Most Recent Annual Report

InflaRx N.V.
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

InflaRx N.V. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!